Oral contraceptives and primary liver cancer: Temporal trends in three countries

Obstetrics and Gynecology

Volumn 88, Issue 6, 1996, Pages 945-949

  Waetjen, L Elaine ^b   Grimes, David A ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER INCIDENCE; CANCER RISK; FEMALE; HUMAN; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; UNITED STATES;

CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; PREVALENCE; SWEDEN; UNITED STATES;

EID: 0030561119     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(96)00340-7     Document Type: Article

References (23)

1. 1. Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983;48:437-40.
2. 2. Neuberger J, Forman D, Doll R, Williams R. Oral contraceptives and hepatocellular carcinoma. BMJ 1986;292:1355-7.
3. 3. Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. BMJ 1986;292:1357-61.
4. 4. Palmer JR, Rosenberg L, Kaufman DW, Warshauer ME, Stolley PD, Shapiro S. Oral contraceptive use and liver cancer. Am J Epidemiol 1989;130:878-82.
5. 5. La Vecchia C, Negri E, Parazzini F. Oral contraceptives and primary liver cancer. Br J Cancer 1989;59:460-1.
6. 6. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
7. 7. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C. Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer 1993;67:635-7.
8. 8. Wanless IR, Medline A. Role of estrogens as promoters of hepatic neoplasms. Lab Invest 1982;46:313-20.
9. 9. La Vecchia C, Negri E, Franceschi S, D'Avanzo B. Reproductive factors and the risk of hepatocellular carcinoma in women. Int J Cancer 1992;52:351-4.
10. 10. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Combined oral contraceptives and liver cancer. Int J Cancer 1989;43:254-9.
11. 11. World Health Organization (WHO). Cancer incidence in five continents, volumes I-VI. Lyon, France: International Agency for Research in Cancer, 1966-1992. Scientific Publications No. 120.
12. 12. U.S. Department of Health and Human Services, Public Health Service. Vital statistics of the United States. Hyattsville, Maryland: National Center for Health Statistics, 1964-1993.
13. 13. World Health Organization. World health statistics annual. Geneva: World Health Organization, 1981-1994.
14. 14. Ross JA, Mauldin WP, Miller VC. Family planning and population: A compendium of international statistics. New York: The Population Council, 1993.
15. 15. Mosher WD, Pratt WF. Contraceptive use in the United States, 1973-88. Pat Ed Coun 1990;16:163-74.
16. 16. Ortho Pharmaceutical Corporation. Report on the 1991 Ortho Annual Birth Control Study. Raritan, New Jersey: Ortho Pharmaceutical Corporation, 1991.
17. 17. Gerstman BB, Gross TP, Kennedy DL, Bennett RC, Tomita DK, Stadel BV. Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health 1991;81:90-6.
18. 18. Ogawa N, Retherford RD. Prospects for increased contraceptive pill use in Japan. Stud Fam Plann 1991;22:378-83.
19. 19. Ranstam J, Hakan O. Oral contraceptive use among young women in southern Sweden. J Epidemiol Community Health 1993;47:32-5.
20. 20. World Health Organization. Oral contraceptives and neoplasia. Geneva: World Health Organization, 1992. WHO Technical Report Series 817.
21. 21. Villard L, Murphy M. Endometrial cancer trends in England and Wales: A possible protective effect of oral contraceptives. Int J Epidemiol 1990;19:255-8.
22. 22. Villard-Mackintosh L, Vessey MP, Jones L. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age. Br J Obstet Gynaecol 1989;96:783-8.
23. 23. Mant JW, Vessey MP. Trends in mortality from primary liver cancer in England and Wales 1975-92: Influence of oral contraceptives. Br J Cancer 1995;72:800-3.